GeoVax Labs, Inc. (GOVX) Q2 2025 Earnings Call Transcript

2025-07-28 19:43:27 ET

GeoVax Labs, Inc. (GOVX)

Q2 2025 Earnings Conference Call

July 28, 2025 04:30 PM ET

Company Participants

David Alan Dodd - Chairman, President & CEO

John W. Sharkey - Vice President of Business Development

Kelly T. McKee - Chief Medical Officer

Mark W. Reynolds - CFO & Corporate Secretary

Conference Call Participants

James Francis Molloy - Alliance Global Partners, Research Division

John D. Vandermosten - Zacks Investment Research, Inc.

Jonathan Matthew Aschoff - ROTH Capital Partners, LLC, Research Division

Robert Michael LeBoyer - NOBLE Capital Markets, Inc., Research Division

Presentation

Operator

Good afternoon, and welcome, everyone, to the GeoVax Second Quarter 2025 Corporate Update Call. My name is Michelle, and I'll facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Vice President, Chief Financial Officer; Mark Newman, PhD, Chief Scientific Officer; Kelly McKee, MD, MPH Chief Medical Officer; and John Sharkey, PhD Vice President, Business Development. [Operator Instructions] As a reminder, this conference is being recorded....

Read the full article on Seeking Alpha

For further details see: